Development of an Injectable, ECM-Derivative Embolic for the Treatment of Cerebral Saccular Aneurysms
Open Access
- 13 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (8) , 4879-4890
Abstract
Cerebral aneurysms are a source of neurological morbidity and mortality, most often as a result of rupture. The most common approach for treating aneurysms involves endovascular embolization using nonbiodegradable medical devices, such as platinum coils. However, the need for retreatment due to the recanalization of coil-treated aneurysms highlights the importance of exploring alternative solutions. In this study, we propose an injectable extracellular matrix-derived embolic formed in situ by Michael addition of gelatin-thiol (Gel-SH) and hyaluronic acid vinyl sulfone (HA-VS) that may be delivered with a therapeutic agent (here, RADA-SP) to fill and remodel aneurysmal tissue without leaving behind permanent foreign bodies. The injectable embolic material demonstrated rapid gelation under physiological conditions, forming a highly porous structure and allowing for cellular infiltration. The injectable embolic exhibited thrombogenic behavior in vitro that was comparable to that of alginate injectables. Furthermore, in vivo studies in a murine carotid aneurysm model demonstrated the successful embolization of a saccular aneurysm and extensive cellular infiltration both with and without RADA-SP at 3 weeks, with some evidence of increased vascular or fibrosis markers with RADA-SP incorporation. The results indicate that the developed embolic has inherent potential for acutely filling cerebrovascular aneurysms and encouraging the cellular infiltration that would be necessary for stable, chronic remodeling.Keywords
Funding Information
- Brain Aneurysm Foundation (AWD00006614, AWD00008508)
This publication has 38 references indexed in Scilit:
- Treatment of Ruptured Wide‐Necked Aneurysms using a Microcatheter Injectable BiomaterialAdvanced Materials, 2023
- Injectable Shear‐Thinning Hydrogels with Sclerosing and Matrix Metalloproteinase Modulatory Properties for the Treatment of Vascular MalformationsAdvanced Functional Materials, 2023
- Sodium Phytate‐Incorporated Gelatin‐Silicate Nanoplatelet Composites for Enhanced Cohesion and Hemostatic Function of Shear‐Thinning BiomaterialsMacromolecular Bioscience, 2022
- Bioabsorbable, elastomer-coated magnesium alloy coils for treating saccular cerebrovascular aneurysmsBiomaterials, 2022
- Treatment of Ruptured and Nonruptured Aneurysms Using a Semisolid Iodinated Embolic AgentAdvanced Materials, 2022
- Injectable hydrogels for vascular embolization and cell delivery: The potential for advances in cerebral aneurysm treatmentBiomaterials, 2021
- Interleukin-1β enhances cell adhesion in human endothelial cells via microRNA-1914–5p suppressionBiochemistry and Biophysics Reports, 2021
- Injection and Self‐Assembly of Bioinspired Stem Cell‐Laden Gelatin/Hyaluronic Acid Hybrid Microgels Promote Cartilage Repair In VivoAdvanced Functional Materials, 2019
- Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia modelBiomaterials, 2013
- In Vitro Assessment of EmboGel and UltraGel Radiopaque Hydrogels for the Endovascular Treatment of AneurysmsJournal of Vascular and Interventional Radiology, 2009